TY - CONF
T1 - Determining acute complicated and uncomplicated appendicitis using serum and urine biomarkers leucine rich alpha-2 glycoprotein 1, neutrophil gelatinase-associated lipocal and interleukin-6
AU - Kakars, Mohits
AU - Broks, Renārs
AU - Asare, Lāsma
AU - Delmore, Mathilde
AU - Berezovska, Marisa M
AU - Zviedre, Astra
AU - Reinis, Aigars
AU - Kroiča, Juta
AU - Eņģelis, Arnis
AU - Saxena, Amulya K
AU - Pētersons, Aigars
PY - 2021/3/24
Y1 - 2021/3/24
N2 - Severe complications
of acute appendicitis (AA) arise with delays in treatment; to avoid
this an early and accurate diagnosis is crucial. Our primary
objective was to demonstrate the potential of leucine-rich
alpha-2 glycoprotein 1
(LRG1), Neutrophil
gelatinase-associated lipocal
(NGAL) and Interleukin-6
(IL-6)
in
differentiating
acute complicated (AcA) from uncomplicated appendicitis (AnA).
In this prospective
single centered cohort study, LRG1,
NGAL, IL-6
in serum and urine levels were assayed preoperatively and on the
second and fifth days postoperatively. Patients were divided into
three groups: AcA, AnA
and a control group without infectious or inflammation-mediated
pathology.
A total of 153 patients participated, of
which 97 had AA and 56 were control. The s-LRG1 levels of AA versus
the control with a cut-off value of 51.69 μg/mL
generated an AUC of 0.95 [95% CI 0.91-0.99, p<0.001]. The cut-off
value of s-LRG1 was 84.06 μg/mL
for diagnosis of AcA when compared to AnA
and therefore, significant [AUC 0.69 95% CI 0.59-0.80,
p=0.001].Median
serum IL-6 and serum NGAL levels Day 0 were higher in appendicitis
versus non-appendicitis. The average serum NGAL on Day 0 were 199.55
ng/mL for AcA, 135.20 ng/mL for AnA and 90.60 ng/mL for the control
group (p = 0.020). The basal average serum IL-6 levels were 79.45
ng/mL for AcA, 23.14 for AnA and 10.93 ng/mL for the control group (p
< 0.001). On the second postoperative day, serum NGAL levels were
higher in AcA vs. AnA (p<0.001).
Serum
LRG1, NGAL and IL-6 are elevated in pediatric appendicitis cases
compared to the control group upon disease presentation. Serum LRG1
and NGAL exhibited excellent diagnostic performance as an
inexpensive, non-invasive, rapid, accurate biomarkers in comparison to
IL-6. The data shows promising results for the usage of these
biomarkers in determining whether a patient has a high risk of
appendicitis that requires surgical treatment.
AB - Severe complications
of acute appendicitis (AA) arise with delays in treatment; to avoid
this an early and accurate diagnosis is crucial. Our primary
objective was to demonstrate the potential of leucine-rich
alpha-2 glycoprotein 1
(LRG1), Neutrophil
gelatinase-associated lipocal
(NGAL) and Interleukin-6
(IL-6)
in
differentiating
acute complicated (AcA) from uncomplicated appendicitis (AnA).
In this prospective
single centered cohort study, LRG1,
NGAL, IL-6
in serum and urine levels were assayed preoperatively and on the
second and fifth days postoperatively. Patients were divided into
three groups: AcA, AnA
and a control group without infectious or inflammation-mediated
pathology.
A total of 153 patients participated, of
which 97 had AA and 56 were control. The s-LRG1 levels of AA versus
the control with a cut-off value of 51.69 μg/mL
generated an AUC of 0.95 [95% CI 0.91-0.99, p<0.001]. The cut-off
value of s-LRG1 was 84.06 μg/mL
for diagnosis of AcA when compared to AnA
and therefore, significant [AUC 0.69 95% CI 0.59-0.80,
p=0.001].Median
serum IL-6 and serum NGAL levels Day 0 were higher in appendicitis
versus non-appendicitis. The average serum NGAL on Day 0 were 199.55
ng/mL for AcA, 135.20 ng/mL for AnA and 90.60 ng/mL for the control
group (p = 0.020). The basal average serum IL-6 levels were 79.45
ng/mL for AcA, 23.14 for AnA and 10.93 ng/mL for the control group (p
< 0.001). On the second postoperative day, serum NGAL levels were
higher in AcA vs. AnA (p<0.001).
Serum
LRG1, NGAL and IL-6 are elevated in pediatric appendicitis cases
compared to the control group upon disease presentation. Serum LRG1
and NGAL exhibited excellent diagnostic performance as an
inexpensive, non-invasive, rapid, accurate biomarkers in comparison to
IL-6. The data shows promising results for the usage of these
biomarkers in determining whether a patient has a high risk of
appendicitis that requires surgical treatment.
M3 - Abstract
SP - 52
T2 - RSU Research week 2021: Knowledge for Use in Practice
Y2 - 24 March 2021 through 26 March 2021
ER -